Study Assessing QBS72S For Treating Brain Metastases

Clinical trial NCT05305365 · ACTIVE_NOT_RECRUITING

Trial details

NCT number: NCT05305365
Sponsor: Stanford University
Status: ACTIVE_NOT_RECRUITING
Phase: Phase 2
Study type: INTERVENTIONAL

Brain Metastases Breast Cancer Lung Cancer Leptomeningeal Disease LMD

Start date: 2022-08-16
Primary completion: 2025-06-20
Enrollment: 21

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.